Development of Diagnostic Recommendations for Vitreoretinal Lymphoma.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY Ocular Immunology and Inflammation Pub Date : 2024-09-01 Epub Date: 2023-02-09 DOI:10.1080/09273948.2023.2173242
Xiao Zhang, Yan Zhang, Wenxue Guan, Dongmei Zou, Chan Zhao, Fei Gao, Rong-Ping Dai, Wei-Hong Yu, You-Xin Chen, Han-Yi Min, Meifen Zhang, Wei Zhang, Xiaoyan Peng
{"title":"Development of Diagnostic Recommendations for Vitreoretinal Lymphoma.","authors":"Xiao Zhang, Yan Zhang, Wenxue Guan, Dongmei Zou, Chan Zhao, Fei Gao, Rong-Ping Dai, Wei-Hong Yu, You-Xin Chen, Han-Yi Min, Meifen Zhang, Wei Zhang, Xiaoyan Peng","doi":"10.1080/09273948.2023.2173242","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To develop diagnostic recommendations for diffuse large B-cell vitreoretinal lymphoma (VRL) in Chinese patients.</p><p><strong>Methods: </strong>Retrospective observational case series. Seventy-three eyes of 40 VRL patients and 8 control patients were analyzed. Eighteen patients from Beijing Tongren Hospital and 46 patients from literature were involved as validations.</p><p><strong>Results: </strong>Diagnostic methods included (1) typical clinical manifestations; (2) vitreous cytology; (3) immunohistochemical examination of vitreous or choroid/retina; (4) aqueous humor or vitreous cytokine; (5) vitreous cell gene rearrangement; (6) vitreous flow cytometry. If patients meet (1)+(2)+(3), or if they meet (1), and two of (4), (5), (6) are positive, they can be diagnosed as VRL. The sensitivity and specificity values for accurate diagnosis were 0.975 and 1.00. One hundred percent eyes from Beijing Tongren Hospital and 92.7% eyes from literature can be diagnosed.</p><p><strong>Conclusion: </strong>We developed diagnostic recommendations for diffuse large B-cell VRL through vitreous cytology combined with multiple auxiliary examinations.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2023.2173242","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To develop diagnostic recommendations for diffuse large B-cell vitreoretinal lymphoma (VRL) in Chinese patients.

Methods: Retrospective observational case series. Seventy-three eyes of 40 VRL patients and 8 control patients were analyzed. Eighteen patients from Beijing Tongren Hospital and 46 patients from literature were involved as validations.

Results: Diagnostic methods included (1) typical clinical manifestations; (2) vitreous cytology; (3) immunohistochemical examination of vitreous or choroid/retina; (4) aqueous humor or vitreous cytokine; (5) vitreous cell gene rearrangement; (6) vitreous flow cytometry. If patients meet (1)+(2)+(3), or if they meet (1), and two of (4), (5), (6) are positive, they can be diagnosed as VRL. The sensitivity and specificity values for accurate diagnosis were 0.975 and 1.00. One hundred percent eyes from Beijing Tongren Hospital and 92.7% eyes from literature can be diagnosed.

Conclusion: We developed diagnostic recommendations for diffuse large B-cell VRL through vitreous cytology combined with multiple auxiliary examinations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
制定玻璃体视网膜淋巴瘤诊断建议。
目的:制定中国患者弥漫大 B 细胞玻璃体视网膜淋巴瘤(VRL)的诊断建议:方法:回顾性观察病例系列。分析了 40 名 VRL 患者和 8 名对照组患者的 73 只眼睛。18例来自北京同仁医院的患者和46例来自文献的患者作为验证:诊断方法包括:(1)典型临床表现;(2)玻璃体细胞学检查;(3)玻璃体或脉络膜/视网膜免疫组化检查;(4)房水或玻璃体细胞因子;(5)玻璃体细胞基因重排;(6)玻璃体流式细胞术。如果患者符合(1)+(2)+(3),或符合(1),且(4)、(5)、(6)中的两项呈阳性,则可诊断为 VRL。准确诊断的灵敏度和特异度分别为 0.975 和 1.00。北京同仁医院100%的眼和文献中92.7%的眼可以确诊:通过玻璃体细胞学结合多种辅助检查,我们提出了弥漫大 B 细胞 VRL 的诊断建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
期刊最新文献
Acinetobacter baumannii Endogenous Endophthalmitis Presenting with Iris Nodules. Autoimmune Retinopathy Following COVID-19: A Case Report. Helicobacter pylori and Its Treatment Impact on Immune-Mediated Ocular Diseases. Epidemiology of Intermediate Uveitis. Limited Utility of Keratic Precipitate Morphology as an Indicator of Underlying Diagnosis in Ocular Inflammation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1